Scientists Screen Existing Drugs in Hopes of Fast-Tracking Zika Treatment
from Johns Hopkins University
A specialized drug screen test using lab-grown human cells has revealed two classes of compounds already in the pharmaceutical arsenal that may work against mosquito-borne Zika virus infections, scientists say. In a summary of their work, published in
, the investigators say they screened 6,000 existing compounds currently in late-stage clinical trials or already approved for human use for other conditions. The screening process identified several compounds that showed the ability to hinder or halt the progress of the Zika virus in lab-grown human neural cells.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063